Quality Of Life

The most burdensome adverse events that patients with asthma reported when using inhaled and oral corticosteroids did not always cause them to stop therapy, according to a study published in Annals of Allergy, Asthma & Immunology.

Adults on medication for heart failure who participated in a yoga therapy program for 1 year saw improvements in quality of life measures, strength and endurance, as well as enhanced left ventricular function, according to a study.

In a phone-led qualitative study, 21 patients with prurigo nodularis expressed that their disease negatively impacts many aspects of their physical, psychological and social well-being.

The Skindex-16, a clinical tool for measuring the skin-related quality of life of patients, showed that patients with autoimmune bullous diseases are greatly impacted by disease flares, according to a study.

Exercise-based rehabilitation interventions were associated with improvements in quality of life and functional exercise capacity for patients with long COVID, according to the results of a meta-analysis published in JAMA Network Open.

Oral challenges confirmed cofactor-dependent wheat allergies, restored quality of life and reduced fear of future reactions, according to a study published in Annals of Allergy, Asthma & Immunology.

Patients with sarcoidosis receiving 40 mg per day of prednisolone had comparable rates of treatment failure and adverse effects to patients receiving 20 mg per day, according to a European Respiratory Society International Congress presentation.

Published results showed a digital intervention package, which included an activity tracker, exercise app and health coach, yielded improvements in pain intensity, pain disability, quality of life and activity after total knee arthroplasty.

An audiovisual-stimulation device improved fibromyalgia symptoms and decreased the use of medications and health care services, according to results of a pilot study presented at PAINWeek.

CHICAGO — In this Healio video exclusive, Silke Gillessen, MD, discusses a study that confirms the triplet combination in de novo, low-volume, metastatic, castration-sensitive prostate cancer as the best course of action.